re: Ann: Raising up to $US17.5m to fast track... Can't help but feel a little disappointed with the funding arrangement. 11.5% at a time when interest rates in the US are at record lows seems a bit excessive especially if the rate rises to 16.5% if their right to convert isn't approved by shareholders. And as though we hadn't given them enough, 3 positions on the board to top it all off!!! Will essentially mean we are borrowing money from them to pay their directors fee!! A company of AOK's size does not require 7 directors.
- Forums
- ASX - By Stock
- AOK
- Ann: Raising up to $US17.5m to fast track Snake R
Ann: Raising up to $US17.5m to fast track Snake R, page-10
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AOK (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.833M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $21.46K | 7.155M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 20533665 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 10674288 | 5 |
Last trade - 13.35pm 15/11/2024 (20 minute delay) ? |
Featured News
AOK (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online